Drug
brentuximab vedotin
1 HCP commentary report on clinical trials studying brentuximab vedotin. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Claims | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| CheckMate 744 NCT02927769 · Bristol-Myers Squibb | Hodgkin lymphoma | Phase 2 | 197 | 19 | Standard | 2026-10-09 | Preview |